Scholars Central

Search Scholars Central

Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.

Advanced searchHide advanced search

In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:

Years

676–700 of 832 articles for Checkpoints

Then save them, add them to a collection or cite them together.
  1. Conference abstract · 7 Mar 2019

    Immunogenic chemotherapy: The basic and the clinical application

    Cancer Science & Therapy

    Oxaliplatin will be a feasible protocol in combination with standard of care treatment, checkpoint inhibitors and multi-peptide active antigen specific immunotherapy in patients with good Karnofsky despite being…

  2. Research article · 1 Mar 2019

    The Results of MSC-428 Nanomolecules Application in Neoadjuvant Therapy in Patients with Breast Cancer

    Journal of Oncopathology and Clinical Research · Volume 3, Issue 1

    infiltration with T cells, reducing the risk of metastasis, inhibiting several very important immune checkpoint proteins, thereby increasing the cytotoxic effect of T-lymphocytes and, accordingly, the duration of disease

  3. Conference abstract · 26 Nov 2018

    Recombinant cyclins and their CDKs in Escherichia coli: expression and purification for soluble active products and characterization with putative inhibitors

    Journal of Proteomics & Bioinformatics

    activation partners, cyclins, are regulators of progression and proliferation through activation of cell cycle checkpoints and inhibited by cyclin-dependent kinase inhibitors (CKIs), thus they have been widely held

  4. Conference abstract · 26 Nov 2018

    The role of programmed death-1 (PD-1) receptors and programmed death receptor ligand-1 (PD-L1) co-inhibitory pathway in the regulation of autoimmune diabetes mellitus (type 1 diabetes mellitus)

    Journal of Clinical and Cellular Immunology

    reinvigorate anergic or exhausted cells. This spurred the development of PD-1 pathway inhibitors (checkpoint blockade) for the treatment of advanced malignancies. Deficiency in, or blocking PD-1 from interacting

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels